Cite
HARVARD Citation
Lingineni, K. et al. (2021). Quantitative Benefit–Risk Assessment of P‐gp–Mediated Drug–Drug Interactions of Dabigatran Coadministered With Pharmacokinetic Enhancers in Patients With Renal Impairment. Clinical pharmacology & therapeutics. 109 (1), pp. 193-200. [Online].